Neutral
Tax-related insider share sale at Crescent Biopharma (CBIO) under Rule 10b5-1
Crescent Biopharma officer Ryan Lynch sold 465 Ordinary Shares on June 22, 2026, at a weighted average price of $17.99 per share. This sale was conduc...